Results 141 to 150 of about 9,042 (190)

Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial. [PDF]

J Immunother Cancer
Gonzalez-Cao M, Sisteré-Oró M, Moran T, Reguart N, Cabezon R, Aguilar Hernández A, Roman R, Molina-Vila MA, Birgin K, Domenjo-Vila E, Piqué G, Lozano M, Charry P, Reyes R, Moya I, Cirera L, Esparre C, Drozdowskyj A, Martínez Pérez E, Rosell R, Juan M, Meyerhans A, Benitez-Ribas D.   +22 more
europepmc   +1 more source

Dendritic cell centric nanoengineering couples antigen acquisition and STING activation for cancer immunotherapy. [PDF]

Cell Rep Med
Xiang S, Ma S, Xu T, Yu W, Wang J, You X, Chai M, Wang X, Wang X, Zhang J, Liu J, Ren X, Song W, Qin T, Li S, Wang J.   +15 more
europepmc   +1 more source

The unfolded protein sensor IRE1 is essential for homeostatic dendritic cell maturation. [PDF]

Nat Commun
Bosteels V, Maréchal S, Cloots E, Fayazpour F, De Nolf C, Van Heddegem L, Tavernier SJ, Rennen S, Amstelveen S, Martens L, Van De Velde E, De Sutter D, Verhee A, Deswarte K, Saelens W, Boon L, Van Duyse J, Van Isterdael G, Guillas I, Saeys Y, De Geest B, Eyckerman S, Mestdagh P, Lambrecht BN, Le Goff W, Janssens S.   +25 more
europepmc   +1 more source

CD4 ^<b>+</b> cell depletion accelerates dendritic cell migration and enhances resident dendritic cell proliferation in tumor-draining lymph nodes. [PDF]

Oncoimmunology
Moriya T, Hashimoto M, Ueda M, Aoyagi T, Kawaguchi A, Takahashi K, Tsukasa K, Doi K, Hemmi H, Kaisho T, Ueha S, Matsushima K, Kusumoto Y, Chtanova T, Tomura M.   +14 more
europepmc   +1 more source

Myeloid dendritic cell subsets characterise muscle in patients with inclusion body myositis and correlate with the IFN-γ pathway and effector T cell markers. [PDF]

Ann Rheum Dis
Kirou RA, Pinal-Fernandez I, Casal-Dominguez M, Pak K, Ikenaga C, Nelke C, Wischnewski S, Preusse C, Del Orso S, Naz F, Islam S, Gutierrez-Cruz G, Lloyd TE, Schirmer L, Ruck T, Stenzel W, Selva-O'Callaghan A, Milisenda JC, Mammen AL.   +18 more
europepmc   +1 more source

EPO Receptor Blockade in Dendritic Cells Enhances Antitumor CD8⁺ T Cell Immunity. [PDF]

Cancer Commun (Lond)
Zhu Y, Cao X.
europepmc   +1 more source

Modeling KRAS mutations in KMT2A::MLLT3 acute myeloid leukemia promotes leukemic progression and transcriptional rewiring. [PDF]

Leukemia
Esparza N, Defrêne J, Bresson E, Soufflet AC, Juárez-Rodríguez MM, Lisi V, Hernández-Sánchez A, Bullinger L, Lavallée VP, Wilhelm BT, Barabé F.   +10 more
europepmc   +1 more source

Dietary sulfur amino acids enhance anti-tumor immunity in colon cancer via an NKT cell-XCL1-cDC1 circuit. [PDF]

Immunity
Lobel L, Fonseca-Pereira D, Nakatsu G, Michaud M, Cao YG, Bae S, Krabak C, Oren Y, Clay SL, El Tekle G, Chun E, Kon S, Chan AT, Clardy J, Glickman JN, Ajami NJ, Day A, Damania A, Baruch EN, White MG, Diggs LP, Wargo J, Riffelmacher T, Balancio A, Kronenberg M, Huttenhower C, Garrett WS.   +26 more
europepmc   +1 more source

KRAS-driven protein disulfide isomerase family A member 6 expression suppresses PRKR-like endoplasmic reticulum kinase-mediated immunogenic cell death to desensitise pancreatic ductal adenocarcinoma to immune checkpoint blockers. [PDF]

Gut
Wang R, Li J, Su D, Yang J, Ma P, Hua L, Luo J, Liu J, Yang R, Zhang L, Shen X, Wang H, Li H, Zhao T, Min J, Liu L, Liao C, Song Y, Su H.   +18 more
europepmc   +1 more source